Synovial Sarcoma Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | EpiZyme Inc, Merck & Co., Inc, Immunocore Ltd, Johnson & Johnson Private Limited, Karyopharm Therapeutics Inc, Novartis A

(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Synovial Sarcoma pipeline constitutes 7+ key companies continuously working towards developing 8+ Synovial Sarcoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Synovial Sarcoma Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Synovial Sarcoma Market.

The Synovial Sarcoma Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Synovial Sarcoma Pipeline Report: https://www.delveinsight.com/sample-request/synovial-sarcoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Synovial Sarcoma treatment therapies with a considerable amount of success over the years.
• Synovial Sarcoma companies working in the treatment market are OncoTherapy Science, Foghorn Therapeutics, BioAtla, Inc., Takara Bio, C4 Therapeutics, Adaptimmune, Epizyme, Inc., and others, are developing therapies for the Synovial Sarcoma treatment
• Emerging Synovial Sarcoma therapies in the different phases of clinical trials are- OTSA101, FHD-609, CAB-AXL-ADC, NY-ESO-1, CFT - 8634, Afamitresgene autoleucel, Tazemetostat, and others are expected to have a significant impact on the Synovial Sarcoma market in the coming years.
• In May 2023, To find out more about the safety and effectiveness of afamitresgene autoleucel in individuals with advanced cancer who are MAGE-A4 positive and HLA-A*02 eligible, ages 2 to 21, Adaptimmune will launch a Phase I/II pediatric basket investigation.
• In December 2022, A rolling biologics license application (BLA) filing for the treatment of patients with advanced synovial sarcoma has been started by Adaptimmune; the submission is anticipated to be finished by mid-2023.The regenerative medicine advanced therapy (RMAT) program of the FDA will allow the application to be reviewed with priority.

Synovial Sarcoma Overview
5-10% of all soft tissue sarcomas (STS) are synovial sarcomas (SS), a distinct subtype of STS. The clinical appearance and unusually early age of diagnosis of synovialsarcoma set it apart from other STS.

Get a Free Sample PDF Report to know more about Synovial Sarcoma Pipeline Therapeutic Assessment-
https://www.delveinsight.com/report-store/synovial-sarcoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Synovial Sarcoma Drugs Under Different Phases of Clinical Development Include:
• OTSA101: OncoTherapy Science
• FHD-609: Foghorn Therapeutics
• CAB-AXL-ADC: BioAtla, Inc.
• NY-ESO-1: Takara Bio
• CFT - 8634: C4 Therapeutics
• Afamitresgene autoleucel: Adaptimmune
• Tazemetostat: Epizyme, Inc.

Synovial Sarcoma Route of Administration
Synovial Sarcoma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Oral
• Parenteral
• Intravenous
• Subcutaneous
• Topical

Synovial Sarcoma Molecule Type
Synovial Sarcoma Products have been categorized under various Molecule types, such as
• Monoclonal Antibody
• Peptides
• Polymer
• Small molecule
• Gene therapy

Synovial Sarcoma Pipeline Therapeutics Assessment
• Synovial Sarcoma Assessment by Product Type
• Synovial Sarcoma By Stage and Product Type
• Synovial Sarcoma Assessment by Route of Administration
• Synovial Sarcoma By Stage and Route of Administration
• Synovial Sarcoma Assessment by Molecule Type
• Synovial Sarcoma by Stage and Molecule Type

DelveInsight's Synovial Sarcoma Report covers around 5+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Further Synovial Sarcoma product details are provided in the report. Download the Synovial Sarcoma pipeline report to learn more about the emerging Synovial Sarcoma therapies at:
https://www.delveinsight.com/sample-request/synovial-sarcoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key companies in the Synovial Sarcoma Therapeutics Market include:
Key companies developing therapies for Synovial Sarcoma are - EpiZyme Inc, Merck & Co., Inc, Immunocore Ltd, Johnson & Johnson Private Limited, Karyopharm Therapeutics Inc, Novartis AG, Pfizer Inc, F. Hoffmann-La Roche Ltd, Bayer AG, Epizyme, Cue Biopharma, Eli Lilly and Company, Adaptimmune Therapeutics Plc, Advenchen Laboratories LLC, Takara Bio Inc, and others.

Synovial Sarcoma Pipeline Analysis:
The Synovial Sarcoma pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Synovial Sarcoma with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Synovial Sarcoma Treatment.
• Synovial Sarcoma key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Synovial Sarcoma Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Synovial Sarcoma market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Download Sample PDF Report to know more about Synovial Sarcoma drugs and therapies- https://www.delveinsight.com/sample-request/synovial-sarcoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Synovial Sarcoma Pipeline Market Drivers
• Increasing Incidence of Synovial Sarcoma, increasing research and development activities for the development of targeted therapies are some of the important factors that are fueling the Synovial Sarcoma Market.

Synovial Sarcoma Pipeline Market Barriers
• However, lack of approved therapies, adverse effects associated with the drugs and other factors are creating obstacles in the Synovial Sarcoma Market growth.

Scope of Synovial Sarcoma Pipeline Drug Insight
• Coverage: Global
• Key Synovial Sarcoma Companies: OncoTherapy Science, Foghorn Therapeutics, BioAtla, Inc., Takara Bio, C4 Therapeutics, Adaptimmune, Epizyme, Inc., and others
• Key Synovial Sarcoma Therapies: OTSA101, FHD-609, CAB-AXL-ADC, NY-ESO-1, CFT - 8634, Afamitresgene autoleucel, Tazemetostat, and others
• Synovial Sarcoma Therapeutic Assessment: Synovial Sarcoma current marketed and Synovial Sarcoma emerging therapies
• Synovial Sarcoma Market Dynamics: Synovial Sarcoma market drivers and Synovial Sarcoma market barriers

Request for Sample PDF Report for Synovial Sarcoma Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/synovial-sarcoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Synovial Sarcoma Report Introduction
2. Synovial Sarcoma Executive Summary
3. Synovial Sarcoma Overview
4. Synovial Sarcoma- Analytical Perspective In-depth Commercial Assessment
5. Synovial Sarcoma Pipeline Therapeutics
6. Synovial Sarcoma Late Stage Products (Phase II/III)
7. Synovial Sarcoma Mid Stage Products (Phase II)
8. Synovial Sarcoma Early Stage Products (Phase I)
9. Synovial Sarcoma Preclinical Stage Products
10. Synovial Sarcoma Therapeutics Assessment
11. Synovial Sarcoma Inactive Products
12. Company-University Collaborations (Licensing/Partnering) Analysis
13. Synovial Sarcoma Key Companies
14. Synovial Sarcoma Key Products
15. Synovial Sarcoma Unmet Needs
16 . Synovial Sarcoma Market Drivers and Barriers
17. Synovial Sarcoma Future Perspectives and Conclusion
18. Synovial Sarcoma Analyst Views
19. Appendix
20. About DelveInsight

Related Reports:

Synovial Sarcoma Market https://www.delveinsight.com/report-store/synovial-sarcoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Synovial Sarcoma Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Synovial Sarcoma Epidemiology https://www.delveinsight.com/report-store/synovial-sarcoma-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Synovial Sarcoma Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports:
Ventricular Assist Devices Market https://www.delveinsight.com/report-store/ventricular-assist-devices-vad-market
Ventricular Assist Devices Market By Product Type (Left Ventricular Assist Devices, Right Ventricular Assist Devices, And Biventricular Assist Devices), By Application Type (Bridge-To-Transplant [Btt], Destination Therapy, And Others), By Design Type (Transcutaneous Ventricular Assist Devcies And Implantable Ventricular Assist Devices), By Type Of Flow (Pulsatile Flow And Continous Flow), By End User (Hospital And Clinics, Ambulatory Surgical Centers, And Others), by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of heart failure and cardiovascular diseases due to obesity, age, & unhealthy lifestyles and rising demand for organ transplants due to increasing prevalence of chronic ailments such as hypertension, diabetes, and others

B-cell Non-hodgkin Lymphoma Market https://www.delveinsight.com/report-store/b-cell-non-hodgkin-lymphoma-market
DelveInsight's "B-Cell Non-Hodgkin Lymphoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the B-Cell Non-Hodgkin Lymphoma, historical and forecasted epidemiology as well as the B-Cell Non-Hodgkin Lymphoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Systemic Sclerosis Market
https://www.delveinsight.com/report-store/systemic-sclerosis-market
DelveInsight's "Systemic Sclerosis Market Insights, Epidemiology, and Market Forecast - 2032" comprehensively analyzes Systemic Sclerosis. The report includes a detailed examination of the historical and projected epidemiology data that includes diagnosed prevalent cases of Systemic Sclerosis segmented by gender-specific, age-specific, and type-specific cases.

Resorbable Vascular Scaffold Market
https://www.delveinsight.com/report-store/resorbable-vascular-scaffolds-market
"DelveInsight's 'Resorbable Vascular Scaffolds Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Resorbable Vascular Scaffolds and the historical and forecasted Resorbable Vascular Scaffolds market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vascular Stents Market
https://www.delveinsight.com/report-store/vascular-stents-market
Vascular Stents Market By Product Type (Coronary Stents, Peripheral Stents [Carotid Stents, Iliac Stents, Femoral Stents, Femoral Stents, Other], Evar Stent Grafts [Abdominal Aortic Aneurysm Stents, Thoracic Aortic Aneurysm Stents]), By Type (Bare-Metal Stents, Drug-Eluting Stents), By Material (Metal And Polymer), By Mode Of Delivery (Balloon-Expandable Stents And Self Expandable Stents), By End-User (Hospitals And Ambulatory Surgical Centers), by geography, is expected to grow at a noteworthy CAGR forecast till 2028 owing to rising burden of vascular diseases across the globe and increasing preferences of minimally invasive surgeries among the patient population.

Bladder Scanners Market
https://www.delveinsight.com/report-store/bladder-scanners-market
"DelveInsight's 'Bladder Scanners Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Bladder Scanners and the historical and forecasted Bladder Scanners market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Vein Illumination Devices Market
https://www.delveinsight.com/report-store/vein-illumination-devices-market
"DelveInsight's 'Vein Illumination Devices Market Insight, Competitive Landscape and Market Forecast, 2028' report delivers an in-depth understanding of Vein Illumination Devices and the historical and forecasted Vein Illumination Devices market trends, globally, which comprises of North America, Europe, APAC, and RoW.

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to launch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Vascular Graft Devices Market
https://www.delveinsight.com/report-store/vascular-grafts-market
Vascular Graft Devices Market By Product Type (Endovascular Grafts [Abdominal And Thoracic], Access Grafts, Peripheral Grafts, And Others), By Type (Knitted, Woven, And Others), By Material (Synthetic[ Polytetrafluoroethylene [PTFE], Polyester, Polyurethane], Biological, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), by geography is expected to register commendable revenue growth at a steady CAGR forecast till 2028 owing to increasing prevalence of cardiovascular diseases such as aortic aneurysms and peripheral artery disease and growing patient for kidney dialysis.

Patient Monitoring Devices Market
https://www.delveinsight.com/report-store/patient-monitoring-devices-market
Patient Monitoring Devices Market By Type Of Devices (Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, Hemodynamic Monitoring Devices, Blood Glucose Monitoring Systems, And Others), By Application (Cardiology, Neurology, Respiratory, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings, And Others), by geography, is anticipated to grow at a significant CAGR till 2028 owing to the growing prevalence of various chronic disorders and integration of advanced technology in the products.

Symptomatic Partial-thickness Rotator Cuff Tears Market
https://www.delveinsight.com/report-store/symptomatic-partial-thickness-rotator-cuff-tears-market
DelveInsight's "Symptomatic Partial-thickness Rotator Cuff Tears Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Symptomatic Partial-thickness Rotator Cuff Tears, historical and forecasted epidemiology as well as the Symptomatic Partial-thickness Rotator Cuff Tears market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+1(919)321-6187
Healthcare Consulting
https://www.delveinsight.com/consulting-services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.